| year | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 0 € | 0 € | 0 € |
Profit | - | - | - |
Assets | 77,6k € -9.2% | 85,5k € +26.6% | 67,5k € +20.7% |
Liabilities | 269 € -77.6% | 1,2k € +548.6% | 185 € -96.6% |
Equity | 77,4k € -8.2% | 84,3k € +25.2% | 67,3k € +33.1% |
Employees | 0 | 0 | 0 -100.0% |
Overall rating | B+75/100 |
Financial health | 70/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Independently | ||||
| - | Independently | ||||
| - | Independently | ||||
| - | Independently |
"Reto slimību izpētes fonds" is located at Ķekavas nov., Ķekavas pag., Vimbukrogs, Kļavu iela 10, LV-2123.
The beneficial owners of "Reto slimību izpētes fonds" are Ainārs Rudzītis, Kristaps Šablinskis, Mārtiņš Kalējs, Nauris Garkaklis and Valdis Verners. View ownership details →
No, "Reto slimību izpētes fonds" does not have an active VAT number and is not registered as a VAT payer.
"Reto slimību izpētes fonds" was founded on January 16, 2014. The company has been operating for 12 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 12 years | - | 0% | |
Equity | 77 365,00 € | - | 0% | |
Assets | 77 634,00 € | - | 0% | |
Fixed assets | 405,00 € | - | 0% | |
Liquidity | 287.10 | - | 90% |
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Registered in the Latvian company register.
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ainārs Rudzītis | LV | ||
| Kristaps Šablinskis | LV | ||
| Mārtiņš Kalējs | LV | ||
| Nauris Garkaklis | LV | ||
| Valdis Verners |
| LV |